Cellectis (CLLS) Cash from Operations (QoQ) (2015 - 2026)
Cellectis (CLLS) Cash from Operations (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.75% |
| Dec 31, 2025 | -559.45% |
| Sep 30, 2025 | 84.76% |
| Jun 30, 2025 | 39.92% |
| Mar 31, 2025 | -36,410.64% |
| Dec 31, 2024 | 99.19% |
| Sep 30, 2024 | -111.17% |
| Jun 30, 2024 | 323.80% |
| Mar 31, 2024 | -164.63% |
| Dec 31, 2023 | 311.03% |
| Sep 30, 2023 | 1.61% |
| Jun 30, 2023 | 34.07% |
| Mar 31, 2023 | -1,270.16% |
| Dec 31, 2022 | 109.84% |
| Sep 30, 2022 | -24.02% |
| Jun 30, 2022 | 38.00% |
| Mar 31, 2022 | -41.17% |
| Dec 31, 2021 | 30.71% |
| Sep 30, 2021 | -150.94% |
| Jun 30, 2021 | 70.38% |